This study is in progress, not accepting new patients
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
Description
Summary
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- 4D Molecular Therapeutics
- ID
- NCT04519749
- Phase
- Phase 1/2 Fabry Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 18 study participants
- Last Updated